These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 19132373)
1. The microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties. Beyer CF; Zhang N; Hernandez R; Vitale D; Nguyen T; Ayral-Kaloustian S; Gibbons JJ Cancer Chemother Pharmacol; 2009 Sep; 64(4):681-9. PubMed ID: 19132373 [TBL] [Abstract][Full Text] [Related]
2. TTI-237: a novel microtubule-active compound with in vivo antitumor activity. Beyer CF; Zhang N; Hernandez R; Vitale D; Lucas J; Nguyen T; Discafani C; Ayral-Kaloustian S; Gibbons JJ Cancer Res; 2008 Apr; 68(7):2292-300. PubMed ID: 18381436 [TBL] [Abstract][Full Text] [Related]
3. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site. Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889 [TBL] [Abstract][Full Text] [Related]
4. Cevipabulin (TTI-237): preclinical and clinical results for a novel antimicrotubule agent. Ayral-Kaloustian S; Zhang N; Beyer C Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):443-7. PubMed ID: 19907719 [TBL] [Abstract][Full Text] [Related]
5. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously. Gapud EJ; Bai R; Ghosh AK; Hamel E Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302 [TBL] [Abstract][Full Text] [Related]
6. 2-cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerization. Zhang N; Ayral-Kaloustian S; Nguyen T; Hernandez R; Beyer C Bioorg Med Chem Lett; 2007 Jun; 17(11):3003-5. PubMed ID: 17416524 [TBL] [Abstract][Full Text] [Related]
8. A high-throughput model for screening anti-tumor agents capable of promoting polymerization of tubulin in vitro. Hu W; Dong H; Li YZ; Hu XT; Han GJ; Qu YB Acta Pharmacol Sin; 2004 Jun; 25(6):775-82. PubMed ID: 15169631 [TBL] [Abstract][Full Text] [Related]
10. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844 [TBL] [Abstract][Full Text] [Related]
11. Tubulin-perturbing naphthoquinone spiroketals. Balachandran R; Hopkins TD; Thomas CA; Wipf P; Day BW Chem Biol Drug Des; 2008 Feb; 71(2):117-24. PubMed ID: 18194192 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin. Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282 [TBL] [Abstract][Full Text] [Related]
13. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel. Dabydeen DA; Florence GJ; Paterson I; Hamel E Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743 [TBL] [Abstract][Full Text] [Related]
14. Interactions of antimitotic peptides and depsipeptides with tubulin. Hamel E Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035 [TBL] [Abstract][Full Text] [Related]
15. The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Hamel E; Sackett DL; Vourloumis D; Nicolaou KC Biochemistry; 1999 Apr; 38(17):5490-8. PubMed ID: 10220336 [TBL] [Abstract][Full Text] [Related]
16. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin. Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents. Kurtzberg LS; Roth SD; Bagley RG; Rouleau C; Yao M; Crawford JL; Krumbholz RD; Schmid SM; Teicher BA Cancer Chemother Pharmacol; 2009 Oct; 64(5):1029-38. PubMed ID: 19277662 [TBL] [Abstract][Full Text] [Related]
18. Microtubule changes in hematologic malignant cells treated with paclitaxel and comparison with vincristine cytotoxicity. Hirose Y; Takiguchi T Blood Cells Mol Dis; 1995; 21(2):119-30. PubMed ID: 8846041 [TBL] [Abstract][Full Text] [Related]
19. Antimicrotubular and cytotoxic activity of geiparvarin analogues, alone and in combination with paclitaxel. Miglietta A; Bocca C; Gabriel L; Rampa A; Bisi A; Valenti P Cell Biochem Funct; 2001 Sep; 19(3):181-9. PubMed ID: 11494307 [TBL] [Abstract][Full Text] [Related]
20. GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol. Shintani Y; Tanaka T; Nozaki Y Cancer Chemother Pharmacol; 1997; 40(6):513-20. PubMed ID: 9332466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]